Comparison of p53 and prohibitin expression in the spectrum of hepatitis, cirrhosis, and hepatocellular carcinoma (2017)
- Authors:
- USP affiliated authors: RAMALHO, FERNANDO SILVA - FMRP ; OLIVEIRA, CARLOS AUGUSTO FERNANDES DE - FZEA ; SILVA, DEISY MARA DA - FMRP ; AUGUSTO, MARLEI JOSIELE - FMRP ; RAMALHO, LEANDRA NAIRA ZAMBELLI - FMRP
- Unidades: FMRP; FZEA
- DOI: 10.20517/2394-5079.2016.39
- Subjects: HEPATITE; CIRROSE HEPÁTICA; CARCINOMA HEPATOCELULAR; APOPTOSE; NEOPLASIAS HEPÁTICAS
- Language: Inglês
- Imprenta:
- Publisher place: Alhambra, CA
- Date published: 2017
- Source:
- Título: Hepatoma Research
- Volume/Número/Paginação/Ano: v. 3, p. 34-42, 2017
- Status:
- Artigo publicado em periódico de acesso aberto (Gold Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
DELLA PORTA, Lívia Maria et al. Comparison of p53 and prohibitin expression in the spectrum of hepatitis, cirrhosis, and hepatocellular carcinoma. Hepatoma Research, v. 3, p. 34-42, 2017Tradução . . Disponível em: https://doi.org/10.20517/2394-5079.2016.39. Acesso em: 30 mar. 2026. -
APA
Della Porta, L. M., Ramalho, F. S., Oliveira, C. A. F. de, Silva, D. M. da, Augusto, M. J., & Ramalho, L. N. Z. (2017). Comparison of p53 and prohibitin expression in the spectrum of hepatitis, cirrhosis, and hepatocellular carcinoma. Hepatoma Research, 3, 34-42. doi:10.20517/2394-5079.2016.39 -
NLM
Della Porta LM, Ramalho FS, Oliveira CAF de, Silva DM da, Augusto MJ, Ramalho LNZ. Comparison of p53 and prohibitin expression in the spectrum of hepatitis, cirrhosis, and hepatocellular carcinoma [Internet]. Hepatoma Research. 2017 ; 3 34-42.[citado 2026 mar. 30 ] Available from: https://doi.org/10.20517/2394-5079.2016.39 -
Vancouver
Della Porta LM, Ramalho FS, Oliveira CAF de, Silva DM da, Augusto MJ, Ramalho LNZ. Comparison of p53 and prohibitin expression in the spectrum of hepatitis, cirrhosis, and hepatocellular carcinoma [Internet]. Hepatoma Research. 2017 ; 3 34-42.[citado 2026 mar. 30 ] Available from: https://doi.org/10.20517/2394-5079.2016.39 - Nonalcoholic steatohepatitis: a search for factual animal models
- Rosmarinic acid attenuates hepatic ischemia and reperfusion injury in rats
- Effect of gallic acid on regression of murine CCL4-induced hepatic cirrhosis
- Riboflavin (vitamin B-2) reduces hepatocellular injury following liver ischaemia and reperfusion in mice
- Inhibition of hepatocarcinogenesis by ArtinM via anti-proliferative and pro-apoptotic mechanisms
- Lectin artinm as a anticarcinogenic agent on Afb1-induced hepatocarcinogenesis in rats
- Molecular changes related to hepatocarcinogenesis in subchronic aflatoxicosis in rats
- Incidence of aflatoxin B1 residues in human liver samples from patients with cirrhosis and hepatocellular carcinoma in Brazil
- Aflatoxin B1 residues in human livers and their relationship with markers of hepatic carcinogenesis
- Oncogenic and tumor suppressor pathways in subchronic aflatoxicosis in rats: association with serum and urinary aflatoxin exposure biomarkers
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
